|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:acquisitionYear
|
1961
|
|
gptkbp:country
|
gptkb:Belgium
|
|
gptkbp:foundedBy
|
gptkb:Paul_Janssen
|
|
gptkbp:foundedYear
|
1953
|
|
gptkbp:headquartersLocation
|
gptkb:Beerse,_Belgium
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Janssen Pharmaceutica
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:logo
|
Janssen Pharmaceutica logo.svg
|
|
gptkbp:notableEmployee
|
gptkb:Paul_Janssen
|
|
gptkbp:notableProduct
|
gptkb:Sirturo
gptkb:Edurant
gptkb:Prezista
gptkb:Risperdal
gptkb:Imodium
gptkb:Daktarin
gptkb:Motilium
gptkb:Nizoral
Fentanyl
|
|
gptkbp:numberOfEmployees
|
over 5000
|
|
gptkbp:originalName
|
gptkb:Janssen_Pharmaceutica_N.V.
|
|
gptkbp:parentCompany
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:researchInterest
|
immunology
infectious diseases
neuroscience
oncology
cardiovascular diseases
|
|
gptkbp:subsidiary
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:type
|
gptkb:subsidiary
|
|
gptkbp:website
|
https://www.janssen.com/
|
|
gptkbp:bfsParent
|
gptkb:pyrazinamide
gptkb:etravirine
gptkb:rilpivirine
gptkb:pimozide
gptkb:mebendazole
gptkb:Beerse,_Belgium
gptkb:Risperdal
gptkb:Paul_Janssen
gptkb:Astex_Therapeutics
gptkb:ketoconazole
gptkb:cisapride
gptkb:loperamide
|
|
gptkbp:bfsLayer
|
6
|